Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO

Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
Drug Metabolism and Disposition December 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
Jasminder Sahi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph H. Stern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Milad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly A. Rose
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Gibson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianxian Zheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Stilgenbauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nalini Sadagopan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Summer Jolley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryl Gilbert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward L. LeCluyse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 12 1370-1376
DOI 
https://doi.org/10.1124/dmd.104.000208
PubMed 
15333513

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 16, 2004
  • Accepted August 24, 2004
  • Published online November 18, 2004.

Article Versions

  • Earlier version (August 27, 2004 - 12:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jasminder Sahi,
  2. Ralph H. Stern,
  3. Mark A. Milad,
  4. Kelly A. Rose,
  5. Gordon Gibson,
  6. Xianxian Zheng,
  7. Linda Stilgenbauer,
  8. Nalini Sadagopan,
  9. Summer Jolley,
  10. Darryl Gilbert and
  11. Edward L. LeCluyse
  1. Departments of Pharmacokinetics, Dynamics and Metabolism (J.S., K.A.R., L.S., N.S.), Experimental Medicine (R.H.S.), Clinical Pharmacokinetics and Pharmacodynamics (M.A.M.), and Molecular Biology (X.Z.), Pfizer Global Research and Development, Ann Arbor, Michigan; Clinical Studies Centers, LLC, Little Rock, Arkansas (G.G.); and Division of Drug Delivery and Disposition, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina (S.J., D.G., E.L.L.)
  1. Address correspondence to:
    Dr. Jasminder Sahi, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor MI 48105. E-mail: Jasminder.Sahi{at}Pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20171129
Sep 20172166
Oct 201722211
Nov 20171163
Dec 20170138
Jan 20182106
Feb 20181207
Mar 20181126
Apr 20180204
May 20182159
Jun 201801313
Jul 20180135
Aug 20180315
Sep 20180277
Oct 201823013
Nov 20181126
Dec 20181658
Jan 2019611
Feb 20191422
Mar 20191421
Apr 20192315
May 20191910
Jun 20191506
Jul 20191731
Aug 20192331
Oct 20191000
Nov 20193602
Dec 20192700
Jan 20201725
Feb 20201433
Mar 2020410
May 20201822
Jun 20201200
Jul 20201201
Aug 2020202
Sep 2020300
Oct 20202400
Nov 20202411
Dec 20202900
Jan 20211310
Feb 20211512
Mar 20211320
Apr 20211210
May 2021850
Jun 2021843
Jul 20211631
Aug 20211152
Sep 20211721
Oct 20211023
Nov 20211831
Dec 20214020
Jan 20221110
Feb 20221023
Mar 20221321
Apr 2022952
May 20221321
Jun 20221631
Jul 20221222
Aug 20222132
Sep 20221931
Oct 20223250
Nov 20221421
Dec 20221450
Jan 20231830
Feb 20231741
Mar 20231495

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (12)
Drug Metabolism and Disposition
Vol. 32, Issue 12
1 Dec 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO

Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
Drug Metabolism and Disposition December 1, 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO

Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert and Edward L. LeCluyse
Drug Metabolism and Disposition December 1, 2004, 32 (12) 1370-1376; DOI: https://doi.org/10.1124/dmd.104.000208
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics